Beyond DNA aptamers, RNA aptamers such as iR3 (anti-FGFR3) and RBM-007 (anti-FGF2) have shown efficacy in preclinical and clinical studies for various conditions, including age-related macular degeneration (AMD) and lung cancer241,.251. The gene discussed is FGFR3; the disease is age-related macular degeneration.